Debra Odink
2013
In 2013, Debra Odink earned a total compensation of $1M as Chief Technology Officer at Anthera Pharmaceuticals, a 90% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $24,276 |
|---|---|
| Option Awards | $648,305 |
| Salary | $340,000 |
| Stock Awards | $31,693 |
| Total | $1,044,274 |
Odink received $648.3K in option awards, accounting for 62% of the total pay in 2013.
Odink also received $24.3K in non-equity incentive plan, $340K in salary and $31.7K in stock awards.
Rankings
In 2013, Debra Odink's compensation ranked 6,404th out of 12,286 executives tracked by ExecPay. In other words, Odink earned more than 47.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,404 out of 12,286 | 48th |
Division Manufacturing | 2,245 out of 4,612 | 51st |
Major group Chemicals And Allied Products | 669 out of 1,466 | 54th |
Industry group Drugs | 485 out of 1,160 | 58th |
Industry Pharmaceutical Preparations | 386 out of 890 | 57th |
Source: SEC filing on April 9, 2015.
Odink's colleagues
We found four more compensation records of executives who worked with Debra Odink at Anthera Pharmaceuticals in 2013.